Follow
Dennis Awuah
Dennis Awuah
Research Fellow, Beckman Research Institute, City of Hope National Medical Center
Verified email at coh.org
Title
Cited by
Cited by
Year
Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5
AD Douglas, AR Williams, E Knuepfer, JJ Illingworth, JM Furze, ...
The Journal of Immunology 192 (1), 245-258, 2014
1642014
The role of indoleamine 2, 3-dioxygenase-aryl hydrocarbon receptor pathway in the TLR4-induced tolerogenic phenotype in human DCs
F Salazar, D Awuah, OH Negm, F Shakib, AM Ghaemmaghami
Scientific Reports 7 (1), 43337, 2017
702017
The mannose receptor negatively modulates the Toll-like receptor 4–aryl hydrocarbon receptor–indoleamine 2, 3-dioxygenase axis in dendritic cells affecting T helper cell …
F Salazar, L Hall, OH Negm, D Awuah, PJ Tighe, F Shakib, ...
Journal of Allergy and Clinical Immunology 137 (6), 1841-1851. e2, 2016
562016
Unbiased analysis of the impact of micropatterned biomaterials on macrophage behavior provides insights beyond predefined polarization states
S Singh, D Awuah, HM Rostam, RD Emes, NK Kandola, D Onion, ...
ACS Biomaterials Science & Engineering 3 (6), 969-978, 2017
492017
Photocrosslinkable gelatin hydrogels modulate the production of the major pro-inflammatory cytokine, TNF-α, by human mononuclear cells
AR Donaldson, CE Tanase, D Awuah, P Vasanthi Bathrinarayanan, L Hall, ...
Frontiers in bioengineering and biotechnology 6, 116, 2018
402018
Holographic optical trapping Raman micro-spectroscopy for non-invasive measurement and manipulation of live cells
F Sinjab, D Awuah, G Gibson, M Padgett, AM Ghaemmaghami, ...
Optics express 26 (19), 25211-25225, 2018
362018
The cross-talk between miR-511-3p and C-type lectin receptors on dendritic cells affects dendritic cell function
D Awuah, M Alobaid, A Latif, F Salazar, RD Emes, AM Ghaemmaghami
The Journal of Immunology 203 (1), 148-157, 2019
202019
CD19/BAFF-R dual-targeted CAR T cells for the treatment of mixed antigen-negative variants of acute lymphoblastic leukemia
X Wang, Z Dong, D Awuah, WC Chang, WA Cheng, V Vyas, SC Cha, ...
Leukemia 36 (4), 1015-1024, 2022
172022
A mathematical modeling approach for targeted radionuclide and chimeric antigen receptor t cell combination therapy
V Adhikarla, D Awuah, AB Brummer, E Caserta, A Krishnan, F Pichiorri, ...
Cancers 13 (20), 5171, 2021
72021
MicroRNA-511-3p mediated modulation of the peroxisome proliferator-activated receptor gamma (PPARγ) controls LPS-induced inflammatory responses in human monocyte derived DCs
D Awuah, A Ruisinger, M Alobaid, C Mbadugha, AM Ghaemmaghami
Immuno 2 (1), 104-117, 2022
32022
Developing a Safer Anti-CD44v6 Chimeric Antigen Receptor T Cell Against Hematological Cancers By Mitigating on-Target Off-Tumor Toxicity
D Awuah, L Stern, I Schrack, TY Kim, J Cohen, R Urak, C Huynh, ...
Blood 138, 2796, 2021
22021
Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma
D Awuah, M Minnix, E Caserta, T Tandoh, V Adhikarla, E Poku, R Rockne, ...
Cancer Immunology, Immunotherapy 72 (8), 2841-2849, 2023
12023
Prevalence of Plasmodium falciparum gametocytaemia in asymptomatic school children before and after treatment with dihydroartemisinin-piperaquine (DP)
B Dinko, D Awuah, K Boampong, JA Larbi, T Bousema, CJ Sutherland
Parasite Epidemiology and Control 21, e00292, 2023
12023
A mathematical model for optimization of combination therapy involving targeted radionuclide and CAR-T cell therapy
V Adhikarla, D Awuah, AB Brummer, E Caserta, A Krishnan, F Pichiorri, ...
Cancer Research 82 (12_Supplement), 2732-2732, 2022
12022
Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy
V Adhikarla, D Awuah, E Caserta, M Minnix, M Kuznetsov, A Krishnan, ...
Frontiers in Immunology 15, 1358478, 2024
2024
Mathematical modeling of targeted radionuclide therapy and CAR-T cell immunotherapy for maximizing therapeutic efficacy in multiple myeloma
V Adhikarla, D Awuah, E Caserta, M Minnix, M Kuznetsov, A Krishnan, ...
Cancer Research 84 (6_Supplement), 7374-7374, 2024
2024
Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression
AM Munoz, R Urak, E Taus, HJ Hsieh, D Awuah, V Vyas, L Lim, K Jin, ...
Molecular Therapy 32 (2), 527-539, 2024
2024
Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myeloma
D Awuah, L Li, L Williams, R Urak, M Kujawski, SJ Forman, JE Shively, ...
Scientific Reports 13 (1), 20853, 2023
2023
Dexamethasone Enhances CAR T Cell Persistence and Function by Upregulating Interleukin 7 Receptor
A Munoz, R Urak, E Taus, C Hsieh, K Jin, SH Lin, D Awuah, V Vyas, ...
bioRxiv, 2022.08. 29.505735, 2022
2022
P-005: Dual specific bivalent CS1 bispecific antibody for cellular immunotherapy against multiple myeloma
D Awuah, L Li, L Williams, R Urak, M Kujawski, S Forman, J Shively, ...
Clinical Lymphoma Myeloma and Leukemia 22, S38-S39, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20